Royal Bank of Canada Reaffirms Outperform Rating for agilon health (NYSE:AGL)

agilon health (NYSE:AGL)‘s stock had its “outperform” rating reissued by analysts at Royal Bank of Canada in a note issued to investors on Tuesday,Benzinga reports. They presently have a $3.00 price objective on the stock. Royal Bank of Canada’s price objective suggests a potential upside of 78.57% from the stock’s previous close.

AGL has been the topic of several other reports. TD Cowen reduced their target price on agilon health from $6.00 to $2.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. Stifel Nicolaus dropped their target price on agilon health from $7.00 to $2.00 and set a “hold” rating on the stock in a report on Tuesday, November 12th. JMP Securities downgraded agilon health from an “outperform” rating to a “market perform” rating in a report on Monday, November 11th. Citigroup decreased their price target on agilon health from $2.50 to $1.75 and set a “sell” rating for the company in a research note on Wednesday, November 13th. Finally, Bank of America downgraded agilon health from a “buy” rating to an “underperform” rating and set a $3.00 target price on the stock. in a report on Wednesday, October 2nd. Three analysts have rated the stock with a sell rating, fifteen have assigned a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat, agilon health currently has a consensus rating of “Hold” and an average target price of $6.05.

agilon health Stock Performance

Shares of NYSE AGL opened at $1.68 on Tuesday. The stock has a market cap of $692.19 million, a price-to-earnings ratio of -1.79 and a beta of 0.60. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. agilon health has a 1-year low of $1.50 and a 1-year high of $13.76. The stock’s 50-day moving average is $2.94 and its 200 day moving average is $4.78.

agilon health (NYSE:AGL) last announced its quarterly earnings results on Thursday, November 7th. The company reported ($0.29) EPS for the quarter, missing analysts’ consensus estimates of ($0.10) by ($0.19). The company had revenue of $1.45 billion during the quarter, compared to analysts’ expectations of $1.47 billion. agilon health had a negative return on equity of 47.84% and a negative net margin of 6.88%. During the same period last year, the firm earned ($0.06) earnings per share. On average, sell-side analysts anticipate that agilon health will post -0.47 EPS for the current fiscal year.

Insider Buying and Selling at agilon health

In related news, CEO Steven Sell bought 20,000 shares of the company’s stock in a transaction dated Thursday, September 12th. The stock was purchased at an average price of $3.36 per share, for a total transaction of $67,200.00. Following the acquisition, the chief executive officer now owns 67,590 shares in the company, valued at $227,102.40. This trade represents a 42.03 % increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at this hyperlink. 3.20% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On agilon health

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Vanguard Group Inc. lifted its stake in shares of agilon health by 1.3% during the 1st quarter. Vanguard Group Inc. now owns 28,947,798 shares of the company’s stock worth $176,582,000 after acquiring an additional 371,537 shares during the last quarter. Capital International Investors raised its position in shares of agilon health by 84.7% in the 1st quarter. Capital International Investors now owns 20,197,932 shares of the company’s stock worth $123,207,000 after acquiring an additional 9,263,296 shares in the last quarter. Quadrature Capital Ltd purchased a new position in agilon health during the 1st quarter worth $185,000. CWM LLC grew its stake in agilon health by 406.5% during the 2nd quarter. CWM LLC now owns 9,081 shares of the company’s stock worth $59,000 after buying an additional 7,288 shares during the last quarter. Finally, Simplicity Wealth LLC grew its stake in agilon health by 145.1% during the 2nd quarter. Simplicity Wealth LLC now owns 26,210 shares of the company’s stock valued at $171,000 after purchasing an additional 15,515 shares during the last quarter.

agilon health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.